Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Cassava Sciences Inc
(NQ:
SAVA
)
30.41
-0.89 (-2.84%)
Streaming Delayed Price
Updated: 12:50 PM EDT, Sep 18, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Cassava Sciences Inc
< Previous
1
2
...
14
15
16
17
18
19
20
21
Next >
Cassava Stock Is a Bold Play That Could Pay Off Soon
September 13, 2021
Bears are attacking SAVA stock as it questions the quality of its clinical data and try to stop its study for treating Alzheimer’s disease.
Via
InvestorPlace
A Reply To Dr Biks on $SAVA PTau-181
September 11, 2021
Data by BruinAnteater @BruinStocks - Twitter, @BruinAnteaterStock - Stocktwits A Quick Introduction Hello, allow me to introduce myself. On twitter I am known as @BruinStocks, and...
Via
Benzinga
What Happens When A Biotech Stock Blows Up: How Our Hedged Portfolio Method Limited The Damage With Cassava Sciences
September 11, 2021
Screen capture via Cassava Sciences' video for their Simulfilam Alzheimer's disease treatment. When A Biotech Stock Goes The Wrong Way In our last post (Corona Doom...
Via
Benzinga
When A Biotech Stock Blows Up
September 11, 2021
How to limit the damage when something goes wrong. We can't always be right, which is why we hedge..
Via
Talk Markets
Cassava Sciences Stock Still Poses Risks After Absorbing Data Controversy
September 09, 2021
Simufilam's eventual approval is still uncertain. Its fading popularity among the Reddit set is a concern as well. Even after it 57%+ price haircut, approach SAVA stock cautiously.
Via
InvestorPlace
Topics
Fraud
Exposures
Legal
Better Buy: Biogen vs. Cassava Sciences
September 04, 2021
These two biotechs are going after a significant market: Alzheimer's.
Via
The Motley Fool
Cassava Plummets — Again — After CEO Denies Data Manipulation Claims
September 03, 2021
Cassava CEO Remi Barbier denied allegations of data manipulation in the firm's Alzheimer's research on Friday. But SAVA stock tumbled, again.
Via
Investor's Business Daily
Cassava CEO Goes Offensive Over Data Allegations
September 03, 2021
Cassava Sciences Inc (NASDAQ: SAVA) has garnered attention recently after a citizen petition with the FDA suggested that the use of Alzheimer's candidate data is based...
Via
Benzinga
Exposures
Product Safety
Fraud Allegations Are Unlikely to Keep Cassava Stock Down
September 03, 2021
Cassava's unchallenged safety and cognition data will result in the FDA allowing it to conduct a Phase 3 trial. SAVA stock is a buy.
Via
InvestorPlace
Topics
Fraud
Exposures
Legal
Product Safety
Cassava Sciences Stock Will Fall Further on Data Manipulation Allegations
September 02, 2021
SAVA stock is still one of the best performers this year, but the recent allegations mean shares will fall further as the story develops.
Via
InvestorPlace
The Daily Biotech Pulse: Cellect Jumps On First Apograft Transplantation, AstraZeneca, European Commission Bury Legal Hatchet, Cassava Defends Itself
September 03, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 2) Abbott Laboratories (NYSE:...
Via
Benzinga
Here's How You Handle a Volatile Stock Like Cassava Sciences
September 02, 2021
Investing in biotech stocks can pay off big, but only if their research pans out. Pay attention to the risk-reward ratio -- and control your greed.
Via
The Motley Fool
12 Health Care Stocks Moving In Wednesday's Intraday Session
September 01, 2021
Gainers Neuronetics (NASDAQ:STIM) stock rose 16.51% to $7.83 during Wednesday's regular session. As of 12:30 EST, this security is trading at a volume of 675.7K shares...
Via
Benzinga
Wait to See How the Cassava Sciences Allegations Pan Out
August 31, 2021
Allegations have been leveled against Cassava Sciences. SAVA stock has fallen by more than 50% as a result. Is this a buy-on-the-dip moment?
Via
InvestorPlace
Insiders Like Cassava Sciences, Which Might Be Good News
August 30, 2021
Insider transactions have historically proven quite prescient for the trajectory of SAVA stock, so what do they imply today?
Via
InvestorPlace
12 Health Care Stocks Moving In Monday's Intraday Session
August 30, 2021
Gainers Valneva (NASDAQ:VALN) stock moved upwards by 29.61% to $49.9 during Monday's regular session. Valneva's stock is trading at a volume of 143.0K shares as of...
Via
Benzinga
Why This Cassava Sciences Analyst Is Dropping Coverage
August 30, 2021
The selling in Cassava Sciences, Inc. (NASDAQ:SAVA) stock ...
Via
Benzinga
3 Reasons Cassava Sciences Stock Isn't Worth the Risk
August 30, 2021
There is a lot of smoke. Is there fire?
Via
The Motley Fool
12 Health Care Stocks Moving In Monday's Pre-Market Session
August 30, 2021
Gainers Valneva (NASDAQ:VALN) stock rose 17.45% to $45.22 during Monday's pre-market session. The market value of their outstanding shares is at $2.2 billion....
Via
Benzinga
Cassava Sciences Is on the Ropes, so Watch for a Dip-Buy Opportunity
August 30, 2021
Amid a regulatory tug-of-war over a proposed Alzheimer's disease treatment, SAVA stock has become a speculator's playground.
Via
InvestorPlace
The Week Ahead In Biotech (Aug. 29- Sept. 4): Merck's Keytruda Regulatory Decision, Stray Earnings On Tap In A Light Week
August 29, 2021
Biopharma stocks had a strong start to the week amid optimism generated by full approval accorded to the mRNA vaccine developed by Pfizer, Inc. and BioNTech SE. The stocks subsequently moved back and...
Via
Talk Markets
The Week Ahead In Biotech (Aug. 29- Sept. 4): Merck's Keytruda Regulatory Decision, Stray Earnings On Tap In a Light Week
August 29, 2021
Biopharma stocks had a strong start to the week amid optimism generated by full approval accorded to the mRNA vaccine developed by Pfizer, Inc. (NYSE: PFE) and BioNTech SE (...
Via
Benzinga
60 Biggest Movers From Friday
August 30, 2021
Gainers Vinco Ventures, Inc. (NASDAQ: BBIG) shares rose 80.9% to close at $5.30 on Friday. The company recently reported a Q2 loss of $5.13 per share. Navios Maritime Acquisition...
Via
Benzinga
Mid-Afternoon Market Update: Crude Oil Rises 2%; Navios Maritime Acquisition Shares Climb On Merger News
August 27, 2021
Toward the end of trading Friday, the Dow traded up 0.63% to 35,436.38 while the NASDAQ rose 1.23% to 15,130.14. The S&P also rose, gaining 0.88% to 4,509.16. The U.S. has the...
Via
Benzinga
Topics
Stocks
Exposures
Fossil Fuels
US Equities
Major Benchmarks Gain Amid Economic Stimulus Commentary
August 27, 2021
Investors are unpacking comments by Federal Reserve Chairman Jerome Powell.
Via
Talk Markets
Topics
Economy
Exposures
Interest Rates
Most Active Equity Options For Midday - Friday, Aug. 27
August 27, 2021
Top Tickers: AAPL, TSLA, AMD, NVDA, PLTR, AMC, BABA, PTON, BBIG, F, SPRT, MSFT, AMZN, FB, PFE, MRNA, BAC, NFLX, SAVA, MARA.
Via
Talk Markets
Mid-Day Market Update: Dow Jumps Over 200 Points; Bill.com Shares Spike Higher
August 27, 2021
Midway through trading Friday, the Dow traded up 0.69% to 35,457.78 while the NASDAQ rose 1.03% to 15,099.70. The S&P also rose, gaining 0.79% to 4,505.38. The U.S. has the...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
35 Stocks Moving In Friday's Mid-Day Session
August 27, 2021
Gainers Support.com, Inc. (NASDAQ: SPRT) shares climbed 87% to $36.83 on abnormally high volume amid continued volatility. The stock has recently been mentioned as a potential...
Via
Benzinga
Why the Cassava Sciences Bears Are Wrong
August 27, 2021
The stock's been a wild ride for investors all year, and it's dropped about 40% in two days. What's going on, and why am I bullish?
Via
The Motley Fool
Why Cassava Sciences Is Plunging Again Today
August 27, 2021
More red flags are emerging for this troubled Alzheimer's biotech company.
Via
The Motley Fool
< Previous
1
2
...
14
15
16
17
18
19
20
21
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.